183 related articles for article (PubMed ID: 23106271)
1. Targeting antibiotic resistance mechanisms in Mycobacterium tuberculosis: recharging the old magic bullets.
Nguyen L
Expert Rev Anti Infect Ther; 2012 Sep; 10(9):963-5. PubMed ID: 23106271
[No Abstract] [Full Text] [Related]
2. Emerging resistant clone of Mycobacterium tuberculosis in west Asia.
Mokrousov I
Lancet Infect Dis; 2016 Dec; 16(12):1326-1327. PubMed ID: 27998587
[No Abstract] [Full Text] [Related]
3. A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers.
Schito M; Dolinger DL
EBioMedicine; 2015 Oct; 2(10):1262-5. PubMed ID: 26629499
[No Abstract] [Full Text] [Related]
4. Counterattacking drug-resistant tuberculosis: molecular strategies and future directions.
Nguyen L; Jacobs MR
Expert Rev Anti Infect Ther; 2012 Sep; 10(9):959-61. PubMed ID: 23106270
[No Abstract] [Full Text] [Related]
5. Multidrug resistant tuberculosis: a continuing crisis.
Burki T
Lancet Infect Dis; 2016 Dec; 16(12):1337-1338. PubMed ID: 27998601
[No Abstract] [Full Text] [Related]
6. [Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis].
Botelho-Nevers E
Med Mal Infect; 2015; 45(1-2):61-2. PubMed ID: 25893234
[No Abstract] [Full Text] [Related]
7. [Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].
Tungusova OS; Mar'iandyshev AO
Probl Tuberk; 2001; (6):48-9. PubMed ID: 11641963
[No Abstract] [Full Text] [Related]
8. Drug-resistant Mycobacterium tuberculosis, Taiwan.
Jou R; Chuang PC; Wu YS; Yan JJ; Luh KT
Emerg Infect Dis; 2006 May; 12(5):871-2. PubMed ID: 16710962
[No Abstract] [Full Text] [Related]
9. Strategies for potentiation of ethionamide and folate antagonists against Mycobacterium tuberculosis.
Wolff KA; Nguyen L
Expert Rev Anti Infect Ther; 2012 Sep; 10(9):971-81. PubMed ID: 23106273
[TBL] [Abstract][Full Text] [Related]
10. Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment.
de Vos M; Ley SD; Wiggins KB; Derendinger B; Dippenaar A; Grobbelaar M; Reuter A; Dolby T; Burns S; Schito M; Engelthaler DM; Metcalfe J; Theron G; van Rie A; Posey J; Warren R; Cox H
N Engl J Med; 2019 May; 380(22):2178-2180. PubMed ID: 31141643
[No Abstract] [Full Text] [Related]
11. Rapid emergence of
Veziris N; Bernard C; Guglielmetti L; Le Du D; Marigot-Outtandy D; Jaspard M; Caumes E; Lerat I; Rioux C; Yazdanpanah Y; Tiotiu A; Lemaitre N; Brossier F; Jarlier V; Robert J; Sougakoff W; Aubry A; ;
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28182568
[No Abstract] [Full Text] [Related]
12. Direct observation therapy-plus can prevent acquired resistance to fluoroquinolones among patients with multidrug-resistant tuberculosis in Taiwan.
Chien JY; Lai CC; Tan CK; Yu CJ; Hsueh PR
Clin Infect Dis; 2013 Apr; 56(7):1054-5. PubMed ID: 23175554
[No Abstract] [Full Text] [Related]
13. Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs.
Viveiros M; Martins M; Rodrigues L; Machado D; Couto I; Ainsa J; Amaral L
Expert Rev Anti Infect Ther; 2012 Sep; 10(9):983-98. PubMed ID: 23106274
[TBL] [Abstract][Full Text] [Related]
14. Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis in a Single Patient.
Baffoe-Bonnie A; Houpt ER; Turner L; Dodge D; Heysell SK
Emerg Infect Dis; 2019 Nov; 25(11):2120-2121. PubMed ID: 31454310
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis.
Whitfield MG; Streicher EM; Dolby T; Simpson JA; Sampson SL; Van Helden PD; Van Rie A; Warren RM
Tuberculosis (Edinb); 2016 Jul; 99():128-130. PubMed ID: 27450014
[TBL] [Abstract][Full Text] [Related]
16. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
Chiang CY
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
[No Abstract] [Full Text] [Related]
17. Linezolid in the treatment of drug-resistant tuberculosis: the way forward?
Yew WW; Lange C
Int J Tuberc Lung Dis; 2014 Jun; 18(6):631-2. PubMed ID: 24903928
[No Abstract] [Full Text] [Related]
18. Acquired drug resistance: we can do more than we think!
Alffenaar JW; Gumbo T; Aarnoutse RE
Clin Infect Dis; 2015 Mar; 60(6):969-70. PubMed ID: 25527653
[No Abstract] [Full Text] [Related]
19. Antibiotic resistance mechanisms in M. tuberculosis: an update.
Nguyen L
Arch Toxicol; 2016 Jul; 90(7):1585-604. PubMed ID: 27161440
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Multidrug-resistant Tuberculosis Infection in Children.
Cruz AT; Garcia-Prats AJ; Furin J; Seddon JA
Pediatr Infect Dis J; 2018 Aug; 37(8):831-834. PubMed ID: 29742640
[No Abstract] [Full Text] [Related]
[Next] [New Search]
